FDA postpones advisory panel meeting on Pfizer COVID vaccine for young kids
(CNN) — The US Food and Drug Administration announced Friday that it is postponing the meeting of its Vaccines and Related Biological Products Advisory Committee, originally scheduled for February 15, as “new data have recently emerged” regarding Pfizer and BioNTech’s emergency use authorization request for their Covid-19 vaccine for children younger than 5.
“This will give the agency time to consider the additional data, allowing for a transparent public discussion as part of our usual scientific and regulatory processes for COVID-19 vaccines. We will provide an update on timing for the advisory committee meeting once we receive additional data on a third dose in this age group from the company’s ongoing clinical trial and have an opportunity to complete an updated evaluation,” acting FDA Commissioner Dr. Janet Woodcock and Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, said in a statement.
This is a developing story and will be updated.
™ & © 2022 Cable News Network, Inc., a WarnerMedia Company. All rights reserved.
Today’s Top Stories
- Bill would allow individuals to become teachers without a bachelor’s degree
- One person killed in wrong-way head-on collision on I-15 near Beck Street
- Two employees found unconscious at Northrop Grumman, died later at hospital
- Salt Lake City police investigating shooting, one person hurt
- The bizarre history of Groundhog Day
- Four elk killed as herd gets too close to I-215 and I-80
- Opinion: Is sportsmanship dead in high school basketball?
- Bill to set target water level for the Great Salt Lake dries up
- Davis County officials charge suspect in Layton Amber Alert
- One man dead, suspect on the run after Glendale shooting